Needham: Maintaining the Rhythm Pharmaceuticals (RYTM.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $50.00 to $46.00.
Needham：维持Rhythm Pharmaceuticals(RYTM.US)评级，由买入调整至买入评级, 目标价由50.00美元调整至46.00美元。
Needham: Maintaining the Rhythm Pharmaceuticals (RYTM.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $50.00 to $46.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.